Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2010 June;145(3) > Giornale Italiano di Dermatologia e Venereologia 2010 June;145(3):323-44

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,311


eTOC

 

REVIEWS  DERMOPATHOLOGY


Giornale Italiano di Dermatologia e Venereologia 2010 June;145(3):323-44

Copyright © 2010 EDIZIONI MINERVA MEDICA

language: English

Cutaneous T-cell lymphoma: important diagnostic tools

Edsall L. C., Patterson J. W.

Department of Pathology, Division of Dermatopathology, University of Virginia, Charlottesville, VA, USA


PDF  


Cutaneous T-cell lymphomas comprise a complex group of disorders with heterogeneous clinical and genotypic features. Of these, mycosis fungoides represents the most common subtype. The diagnosis of these entities remains a challenging process due to their diverse clinical presentations and subtle microscopic features. Evaluation currently relies upon clinical criteria, in combination with histochemical, immunological and molecular studies. Recent algorithms have been proposed using criteria that incorporate each of these approaches. This review will focus on tools and techniques utilized for the diagnosis of cutaneous T-cell lymphomas classified within the most recent World Health Organization/European organization for Research and Treatment of Cancer (WHO/EORTC) consensus criteria. Particular emphasis will be placed on mycosis fungoides and Sézary syndrome. Key features facilitating the clinical and microscopic interpretations will be outlined, as well as a synopsis of the advances made in the use of techniques such as immunohistochemistry, flow cytometry and gene rearrangement. We will also consider some recently reported novel approaches that explore these complex diseases at the molecular and genetic levels.

top of page

Publication History

Cite this article as

Corresponding author e-mail

lcedsall@gmail.com